<DOC>
	<DOCNO>NCT02632890</DOCNO>
	<brief_summary>The purpose study determine ) implementation abatacept ( OrenciaÂ® ) patient alert card ( PAC ) result effective understanding key safety message b ) degree understand key safety message associate improved clinical safety outcome .</brief_summary>
	<brief_title>Assessment Effectiveness IV SC Abatacept ( Orencia ) Patient Alert Cards Patients With Rheumatoid Arthritis Sample EU Countries</brief_title>
	<detailed_description>3 sub study : 2 Cross-Sectional 1 retrospective chart review</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Patient survey ( cohort 1 ) : 1 . Patients take abatacept within previous 3 month rheumatoid arthritis 2 . Patient 18 year age HCP survey ( cohort 2 ) : ) Physician nurse work rheumatology center , least 1 patient take abatacept previous 6 month rheumatoid arthritis ( prescribe , administer follow ) Retrospective chart review study ( cohort 3 ) : 1 . Patient survey questionnaire complete , Informed Consent Form ( ICF ) sign Patient survey : 1 . Patient participate clinical trial arthritis previous 12 month 2 . Currently employee BMS HCP survey : 1 . Physicians nurse recruit patient Patient survey 2 . Currently employee BMS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>